| __timestamp | Johnson & Johnson | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 8494000000 | 4101058 |
| Thursday, January 1, 2015 | 9046000000 | 10763215 |
| Friday, January 1, 2016 | 9095000000 | 5579049 |
| Sunday, January 1, 2017 | 10554000000 | 32051299 |
| Monday, January 1, 2018 | 10775000000 | 24482286 |
| Tuesday, January 1, 2019 | 11355000000 | 43892589 |
| Wednesday, January 1, 2020 | 12340000000 | 44505000 |
| Friday, January 1, 2021 | 14277000000 | 79406000 |
| Saturday, January 1, 2022 | 14135000000 | 49283000 |
| Sunday, January 1, 2023 | 15048000000 | 17282730 |
| Monday, January 1, 2024 | 17232000000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceutical innovation, research and development (R&D) spending is a critical indicator of a company's commitment to future growth. Over the past decade, Johnson & Johnson and Verona Pharma plc have demonstrated contrasting approaches to R&D investment.
Johnson & Johnson, a global healthcare giant, has consistently increased its R&D expenses, with a notable 77% rise from 2014 to 2023. This strategic investment underscores their dedication to pioneering medical advancements. In contrast, Verona Pharma plc, a smaller player, has shown a more volatile R&D spending pattern, peaking in 2021 with a 93% increase from 2014, before a significant drop in 2023.
These trends highlight the diverse strategies within the pharmaceutical sector, where established leaders and emerging innovators navigate the complex path of drug development and market competition.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Biogen Inc.
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Investment: Zoetis Inc. vs Verona Pharma plc
Research and Development Investment: Sarepta Therapeutics, Inc. vs Verona Pharma plc
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Analyzing R&D Budgets: Verona Pharma plc vs CRISPR Therapeutics AG
Research and Development: Comparing Key Metrics for Verona Pharma plc and Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Verona Pharma plc and HUTCHMED (China) Limited
R&D Spending Showdown: Verona Pharma plc vs Dynavax Technologies Corporation
Analyzing R&D Budgets: Verona Pharma plc vs Travere Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Celldex Therapeutics, Inc.